Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
口服重组修饰的 SARS-CoV-2 RBD 抗原可作为 COVID-19 护理的免疫刺激剂
期刊:Microbial Cell Factories
影响因子:4.3
doi:10.1186/s12934-024-02320-5
Norma A Valdez-Cruz, Diego Rosiles-Becerril, Constanza E Martínez-Olivares, Enrique García-Hernández, Laura Cobos-Marín, Daniel Garzón, Francisco E López-Salas, Guadalupe Zavala, Axel Luviano, Alejandro Olvera, Alejandro Alagón, Octavio T Ramírez, Mauricio A Trujillo-Roldán
代谢
免疫
心血管
新冠
ELISA
ICC
IHC
Human